Mayo Clinic Laboratories, Helix collaborate to provide suite of laboratory services to biopharma customers

By The Science Advisory Board staff writers

January 10, 2023 -- Mayo Clinic Laboratories and Helix on Tuesday announced a strategic collaboration that will provide biopharma customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle.

The offering will include a full spectrum of testing capabilities that leverages both Helix's suite of next generation sequencing capabilities and Mayo Clinic Laboratories' portfolio of more than 3,800 tests and pathology services.

Mayo Clinic Laboratories said that with Helix it will provide biopharma customers with full end-to-end laboratory testing support.

Financial and other terms of the collaboration were not disclosed.

"In addition to the testing knowledge, our Mayo Clinic physicians and scientists are available for consultation during this process to provide their expertise and guidance," Dr. William Morice II, president and CEO of Mayo Clinic Laboratories, said in a statement.

The collaboration builds upon an existing relationship between the two organizations. Helix collaborates with the Mayo Clinic Center for Individualized Medicine Tapestry program, which is a 100,000-participant population genomics program. All participants in this program are sequenced using Helix's Exome+ assay at the firm's clinical laboratory in San Diego.

Mayo Clinic, Hibiscus BioVentures, Innoforce partner on cell and gene therapy accelerator
The Mayo Clinic, Hibiscus BioVentures, and Innoforce have teamed up to advance new cures for serious and complex diseases with cell and gene therapies...
Mayo Clinic, National Resilience to create center for biomanufacturing regenerative technologies
The Mayo Clinic and biotech company National Resilience have announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics...

Copyright © 2023

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter